Compare Danaher Corporation (DHR) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Danaher Corporation trades at $203.89 (market cap $144.67B), while YieldMax Universe Fund of Option Income ETFs trades at $7.68. The key difference: Danaher Corporation pays a 0.78% dividend while YieldMax Universe Fund of Option Income ETFs pays none, and Danaher Corporation is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| DHR | YMAX | |
|---|---|---|
Market Cap | $144.67B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $242.05 | $13.14 |
52-Week Low | $161.91 | $7.27 |
Enterprise Value | $166.88B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $204.02, down 1.65% on the day, with a bullish technical outlook supported by moving averages and a recent history of earnings beats. The company maintains strong profitability margins and positive cash flow, though revenue growth has moderated. Recent news highlights product launches and a pending acquisition of Masimo, approved by shareholders in May 2026.
The stock presents a balanced outlook with solid fundamentals and analyst support, but faces risks from integration challenges and macroeconomic pressures. Upside is supported by a consensus price target of $202.33, while valuation multiples remain elevated relative to historical norms.
YMAX trades at $7.63, down 1.04% today, with a bullish technical signal but mixed momentum indicators. The ETF maintains a consistent weekly dividend distribution schedule, though recent news highlights concerns over fee structures impacting payouts. Support and resistance levels cluster around $8, indicating potential consolidation near current prices.
Outlook remains cautious due to high fees eroding yields and technical overbought signals. Risks include cost inefficiencies and dependency on market volatility for strategy performance. Analyst sentiment is mixed, balancing income appeal against structural expenses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
